Recent articles

Nearly 3 years after Breakthrough T1D joined forces with Civica, a non-profit pharmaceutical company, its first insulin is now available for purchase at pharmacies across the country. Check out our story from October that highlights the years of partnership between Civica and Breakthrough T1D that made today a reality. We worked with our partners at […]

Ride 2025 Wrapped

You rode. We cheered you on. Together, we fueled type 1 diabetes breakthroughs! Read our wrap-up of the Breakthrough T1D Ride 2025 season.

See Medical Affairs. See T1D.

Closing the gap between access to and adoption of type 1 diabetes therapies is a mission priority. Chris Dunn represents these efforts in action.

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the Latest T1D Updates

Sign up for our monthly mission progress newsletter, The Pipeline, to stay up to date on everything you need to know about T1D, from research to advocacy, to clinical care – and everything in between.

  • This field is for validation purposes and should be left unchanged.